SOL SPA (IT:SOL)
:SOL
Want to see IT:SOL full AI Analyst Report?
Top Page
SOL SPA
(SOL)
Select Model
Select Model
Rating:67Neutral
Price Target:
€64.00
▲(9.40% Upside)
Action:DowngradedDate:04/27/26
The score is driven primarily by solid operating performance but constrained by weakening free cash flow and higher 2025 leverage. Technicals are supportive with a strong uptrend and positive momentum, while valuation is a headwind due to a higher P/E and low dividend yield.
Positive Factors
Consistent Revenue Growth
Sustained multi-year revenue growth indicates durable demand for the company’s products and incremental market penetration. Over 2–6 months this underpins stable top-line momentum, supports capacity utilization and planning, and reduces execution risk versus one-off cycles.
Negative Factors
Weakened Free Cash Flow
Declining free cash flow reduces financial flexibility for dividends, buybacks, or debt reduction. Over the medium term this limits the company’s ability to self-fund growth or absorb shocks, increasing dependence on external financing if capex or working capital remain elevated.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained multi-year revenue growth indicates durable demand for the company’s products and incremental market penetration. Over 2–6 months this underpins stable top-line momentum, supports capacity utilization and planning, and reduces execution risk versus one-off cycles.
Read all positive factors
SOL SPA (SOL) vs. iShares MSCI Italy ETF (EWI)
Market Cap
€5.22B
Dividend Yield0.8%
Average Volume (3M)31.19K
Price to Earnings (P/E)26.6
Beta (1Y)0.49
Revenue Growth10.29%
EPS Growth13.07%
CountryIT
Employees7,200
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)0.92
Shares Outstanding90,700,000
10 Day Avg. Volume35,913
30 Day Avg. Volume31,190
Financial Highlights & Ratios
PEG Ratio2.06
Price to Book (P/B)3.91
Price to Sales (P/S)2.50
P/FCF Ratio178.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€57.75Price Target Upside-1.28% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)2.05
Revenue Forecast (FY)€1.92B
SOL SPA Business Overview & Revenue Model
Company Description
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases; and in home medical assistance and related medical equipment in Italy and internationally. The company offers technical and medical gases, includ...
SOL SPA Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
67
Positive
Cash Flow
52
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.78B | 1.61B | 1.49B | 1.38B | 1.11B |
| Gross Profit | 292.90M | 1.17B | 641.49M | 290.04M | 250.18M |
| EBITDA | 439.84M | 391.08M | 372.51M | 319.04M | 255.41M |
| Net Income | 166.99M | 147.70M | 145.73M | 133.69M | 89.55M |
Balance Sheet | |||||
| Total Assets | 2.42B | 2.14B | 1.94B | 1.72B | 1.44B |
| Cash, Cash Equivalents and Short-Term Investments | 364.71M | 244.14M | 220.15M | 147.43M | 139.64M |
| Total Debt | 851.70M | 573.61M | 620.54M | 461.36M | 460.40M |
| Total Liabilities | 1.23B | 1.06B | 965.54M | 855.95M | 723.00M |
| Stockholders Equity | 1.14B | 1.03B | 928.61M | 820.62M | 698.26M |
Cash Flow | |||||
| Free Cash Flow | 24.88M | 47.43M | 65.11M | 53.74M | 44.81M |
| Operating Cash Flow | 276.77M | 297.49M | 270.06M | 214.92M | 192.56M |
| Investing Cash Flow | -286.67M | -266.37M | -246.69M | -252.30M | -229.52M |
| Financing Cash Flow | 120.05M | -7.88M | 52.42M | 30.34M | -93.53M |
SOL SPA Technical Analysis
Positive
58.50
Price Trends
52.20
Positive
50.37
Positive
50.09
Positive
Market Momentum
1.80
Positive
61.23
Neutral
21.53
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:SOL, the sentiment is Positive. The current price of 58.5 is above the 20-day moving average (MA) of 56.10, above the 50-day MA of 52.20, and above the 200-day MA of 50.09, indicating a bullish trend. The MACD of 1.80 indicates Positive momentum. The RSI at 61.23 is Neutral, neither overbought nor oversold. The STOCH value of 21.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:SOL.
SOL SPA Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | €5.22B | 26.59 | 15.43% | 0.80% | 10.29% | 13.07% | |
64 Neutral | €7.60B | 9.65 | 13.08% | 4.37% | 9.30% | -13.13% | |
64 Neutral | €4.75B | 9.79 | 14.57% | 4.33% | -33.27% | 44.64% | |
63 Neutral | €100.79B | 22.77 | 23.22% | 5.05% | 1.73% | -39.94% | |
63 Neutral | €5.88B | 8.70 | 13.30% | 3.76% | -0.60% | -7.61% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IT:SOL
SOL SPA
57.60
17.02
41.93%
IT:A2A
A2A SpA
2.43
0.30
13.96%
IT:ACE
ACEA SPA
22.34
2.54
12.83%
IT:EDNR
Edison Spa
2.20
0.43
24.29%
IT:ENEL
Enel S.p.A.
9.92
2.68
36.94%
IT:HER
HERA S.p.A.
4.02
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.